Asterand plc has announced that it has signed a partnership with Rubicon Genomics to discover biomarkers for cancer diagnosis. Under the non-exclusive agreement, Asterand will supply tissue and biofluid samples from its biorepository and its worldwide network of clinical collaborators. PharmacoGenomicsOnline.com (http://www.pharmacogenomicsonline.com/index.aspx?ID=73605)